Showing 1-1 of 2

Paris Prevention in General Practice
France, 2004-2006
Laurent;RIGAL
ID: FRESH-PEF32383-en Last modified: Dec 18, 2025
Paris Registry of Congenital Malformations
France, 1981-2011
Babak;KHOSHNOOD
ID: FRESH-PEF221-en Last modified: Dec 18, 2025
Patient Acceptable Symptomatic State
France, 2009-2010
Franck;VIGNAL
ID: FRESH-PEF93-en Last modified: Dec 18, 2025 Views: 13
Patient reported Instanyl Use Study
France, 2011-2012
Nicholas;MOORE, Patrick;BLIN
ID: FRESH-PEF2943-fr Last modified: Dec 18, 2025
Patient reported Instanyl® Use Study
France, 2011-2012
Nicholas;MOORE, Patrick;BLIN
ID: FRESH-PEF2943-en Last modified: Dec 18, 2025
Patients with Marfan Syndrome or Related Conditions
France, 1996
Guillaume;JONDEAU
ID: FRESH-PEF60099-en Last modified: Dec 18, 2025
Patients with Schizophrenic or Schizoaffective Disorders
France, 2001-2004
Jean-Michel;AZORIN
ID: FRESH-PEF73188-en Last modified: Dec 18, 2025
Pediatric cancer registry of western France
France, 2013
Isabelle;PELLIER
ID: FRESH-PEF73258-en Last modified: Dec 18, 2025
Perceptions and impact of the Covid-19 epidemic in housing facilities for socially excluded individuals
France, 2020
Simon;DUCARROZ, Maria;MELCHIOR
ID: FRESH-PEF73881-en Last modified: Dec 18, 2025
Perceptions, connaissances et comportements du grand public vis-à-vis de la maladie d’Alzheimer
France, 2008-2013
Christophe;LEON
ID: FRESH-PEF73148-fr Last modified: Dec 18, 2025
Persistence of combination of evidence-based medical therapies in patients with recent history of ACS in primary care setting
France, 2006-2007
Nathalie;SCHMIDELY, Elisabeth;AMELINEAU
ID: FRESH-PEF139-en Last modified: Dec 18, 2025
Persistence of evidence-based medical therapies over time in patients monitored by cardiologists after a first recent ACS
France, 2006-2007
Elisabeth;AMELINEAU, Nathalie;SCHMIDELY
ID: FRESH-PEF138-en Last modified: Dec 18, 2025
PERSONNES AGEES QUID
France, 1988-2018
Jean-François;DARTIGUES
ID: FRESH-PEF3514-en Last modified: Dec 18, 2025
Select number of records to show per page: 15 30 50 100